MARSHALL WACE, LLP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$3,390,000
+89.4%
121,032
+84.6%
0.01%
+100.0%
Q4 2021$1,790,000
+248.2%
65,558
+118.0%
0.00%
+50.0%
Q2 2021$514,000
+102.4%
30,076
+93.1%
0.00%0.0%
Q3 2020$254,000
-89.4%
15,577
-81.6%
0.00%
-91.7%
Q4 2018$2,392,000
-47.5%
84,886
-46.5%
0.02%
+26.3%
Q3 2018$4,560,000
-11.1%
158,598
-47.4%
0.02%
-92.3%
Q1 2017$5,129,000
+1290.0%
301,698
+1455.1%
0.25%
+6100.0%
Q1 2016$369,00019,4000.00%
Other shareholders
INTERSECT ENT INC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders